155 related articles for article (PubMed ID: 9088427)
1. Exoantigens from trypanosoma cruzi contain cruzipain.
Gruppi A; Cerbán FM; Vottero-Cima E
Acta Trop; 1997 Feb; 63(2-3):141-9. PubMed ID: 9088427
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi: immunological cross-reactivity of the major cysteinyl proteinase (cruzipain) with a parasite cytosol acidic antigen (FIV).
Cerban FM; Motran C; Laderach D; Gea S; Gruppi A; Vottero-Cima E
Acta Trop; 1994 Dec; 58(3-4):337-43. PubMed ID: 7709872
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).
Laderach D; Cerban F; Motran C; Vottero de Cima E; Gea S
Int J Parasitol; 1996 Nov; 26(11):1249-54. PubMed ID: 9024869
[TBL] [Abstract][Full Text] [Related]
4. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.
Martinez J; Campetella O; Frasch AC; Cazzulo JJ
Infect Immun; 1991 Nov; 59(11):4275-7. PubMed ID: 1937786
[TBL] [Abstract][Full Text] [Related]
5. The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains.
Martínez J; Campetella O; Frasch AC; Cazzulo JJ
Immunol Lett; 1993 Feb; 35(2):191-6. PubMed ID: 7685319
[TBL] [Abstract][Full Text] [Related]
6. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
7.
Chain CY; Pires Souto DE; Sbaraglini ML; Labriola CA; Daza Millone MA; Ramirez EA; Cisneros JS; Lopez-Albizu C; Scollo K; Kubota LT; Ruiz AM; Vela ME
ACS Infect Dis; 2019 Nov; 5(11):1813-1819. PubMed ID: 31538468
[No Abstract] [Full Text] [Related]
8. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
9. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
Zúñiga E; Montes C; Barbieri G; Gruppi A
Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).
Malchiodi EL; Chiaramonte MG; Taranto NJ; Zwirner NW; Margni RA
Clin Exp Immunol; 1994 Sep; 97(3):417-23. PubMed ID: 8082296
[TBL] [Abstract][Full Text] [Related]
12. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase.
Arnholdt AC; Piuvezam MR; Russo DM; Lima AP; Pedrosa RC; Reed SG; Scharfstein J
J Immunol; 1993 Sep; 151(6):3171-9. PubMed ID: 7690795
[TBL] [Abstract][Full Text] [Related]
13. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring.
Giordanengo L; Maldonado C; Rivarola HW; Iosa D; Girones N; Fresno M; Gea S
Eur J Immunol; 2000 Nov; 30(11):3181-9. PubMed ID: 11093133
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi exoantigens: can those recognized by sera from chagasic patients trigger a protective immune response in mice?
Gruppi A; Pistoresi-Palencia MC; Cerban F; Vottero-Cima E
Res Immunol; 1991; 142(9):821-8. PubMed ID: 1796212
[TBL] [Abstract][Full Text] [Related]
15. Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection.
Cazorla SI; Frank FM; Becker PD; Arnaiz M; Mirkin GA; Corral RS; Guzmán CA; Malchiodi EL
J Infect Dis; 2010 Jul; 202(1):136-44. PubMed ID: 20497050
[TBL] [Abstract][Full Text] [Related]
16. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite.
Giordanengo L; Guiñazú N; Stempin C; Fretes R; Cerbán F; Gea S
Eur J Immunol; 2002 Apr; 32(4):1003-11. PubMed ID: 11920566
[TBL] [Abstract][Full Text] [Related]
17. Identity of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi and an antigen (Ag163B6) isolated with a monoclonal antibody.
Malchiodi EL; Chiaramonte MG; Martínez JA; Zwirner NW; Margni RA; Cazzulo JJ
Immunol Lett; 1993 Jan; 35(1):59-62. PubMed ID: 8458637
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL
Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408
[TBL] [Abstract][Full Text] [Related]
19. Expression of a recombinant Fab antibody fragment against cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Kaplan D; Baldi C; Chiaramonte MG; Fernandez MM; Levin MJ; Malchiodi E; Baldi A
Biochem Biophys Res Commun; 1998 Dec; 253(1):53-8. PubMed ID: 9875219
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease.
Duschak VG; Riarte A; Segura EL; Laucella SA
Immunol Lett; 2001 Oct; 78(3):135-42. PubMed ID: 11578687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
